Semi-Annual Statement Of Income

Kringle Pharma,Inc. - Filing #7264672

Concept 2024-10-01 to
2025-03-31
2023-10-01 to
2024-03-31
Semi-annual statement of income
Statement of income
Net sales
35,928,000 JPY
43,029,000 JPY
Cost of sales
JPY
JPY
Ordinary profit (loss)
-511,740,000 JPY
-365,471,000 JPY
Gross profit (loss)
35,928,000 JPY
43,029,000 JPY
Selling, general and administrative expenses
547,862,000 JPY
409,776,000 JPY
Selling, general and administrative expenses
Profit (loss) before income taxes
-511,740,000 JPY
-365,471,000 JPY
Operating profit (loss)
-511,933,000 JPY
-366,746,000 JPY
Income taxes - current
749,000 JPY
746,000 JPY
Non-operating income
257,000 JPY
1,275,000 JPY
Non-operating income
Interest income
29,000 JPY
7,000 JPY
Income taxes
749,000 JPY
746,000 JPY
Non-operating expenses
65,000 JPY
JPY
Profit (loss)
-512,490,000 JPY
-366,217,000 JPY
Non-operating expenses

Talk to a Data Expert

Have a question? We'll get back to you promptly.